Electroporation to deliver chemotherapeutics and enhance tumor regression
AssigneeThe Regents of the University of California
InventorsBoris Rubinsky, Jon Edd, Liana Horowitz
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsBoris Rubinsky, Jon Edd, Liana Horowitz
Estimating the term…
A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
A method of disrupting capillary blood flow and facilitating the permeation of an agent into a target area of tissue, comprising the steps of:
A method of treating cancer, comprising:
A method of enhancing the delivery of an agent into a target area of tissue, comprising the steps of:
Dependencies are inferred from the claim text.